A5018595577- Hepatocellular Carcinoma Treatment and Prognosis
- Cholangiocarcinoma and Gallbladder Cancer Studies
- Urinary Tract Infections Management
- Cardiovascular Disease and Adiposity
- Bladder and Urothelial Cancer Treatments
- Renal cell carcinoma treatment
- Urinary Bladder and Prostate Research
- Testicular diseases and treatments
- Tissue Engineering and Regenerative Medicine
- Radiopharmaceutical Chemistry and Applications
- Pelvic floor disorders treatments
- Vascular anomalies and interventions
- Urological Disorders and Treatments
- Pancreatic and Hepatic Oncology Research
- Advanced Radiotherapy Techniques
- Medical Imaging and Pathology Studies
University Medical Center Utrecht
2024
Mater Misericordiae University Hospital
2018
Abstract Purpose An international survey was conducted by the Cardiovascular Interventional Radiological Society of Europe (CIRSE) to evaluate radioembolization practice and capture opinions on real-world clinical technical aspects this therapy. Materials Methods A with 32 multiple choice questions sent as an email CIRSE members between November December 2022. group member sister societies promoted their local members. The dataset cleaned duplicates entries missing data, resulting anonymized...
Abstract Background Personalised multi-compartment dosimetry based on [ 99m Tc]Tc-MAA is a valuable tool for planning 90 Y radioembolization treatments. The establishment and effective application of dose–effect relationships in yttrium-90 ( Y) requires SPECT quantification ideally independent clinical site. purpose this multi-centre phantom study was to evaluate inter-site variability imaging standardised protocol. Data obtained from the TARGET study, an international, retrospective...